Fig. 2
From: GVHD-derived plasma as a priming strategy of mesenchymal stem cells
Immunophenotypic characterization of MSCs. a The expression of CD44, CD73, CD90, and CD105 was analyzed in control (MSCs primed with pooled plasma from healthy donors), as well in MSCs primed with aGVHD (acute GVHD) and cGVHD (chronic GVHD) by flow cytometry. b Representative histograms of single MSC samples investigated in each experimental group. c HLA-DR expression in control MSCs, as well as in MSCs primed with aGVHD (acute GVHD) and cGVHD (chronic GVHD)